SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer

SPARC Ameliorates Ovarian Cancer-Associated Inflammation

(2015) Neveen A. Said et al.   NEOPLASIA

Inflammation-dependent expression of SPARC during development of chronic pancreatitis in WBN/Kob rats and a microarray gene expression analysis

(2009) T. Reding et al.   PHYSIOLOGICAL GENOMICS

Roles for Inflammation and Regulatory T Cells in Colon Cancer

(2009) Susan E. Erdman et al.   TOXICOLOGIC PATHOLOGY

SPARC: a matricellular regulator of tumorigenesis

(2009) Shanna A. Arnold et al.   Journal of Cell Communication and Signaling

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

(2008) S Cheetham et al.   BRITISH JOURNAL OF CANCER

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

(2008) Giuseppe Perrone et al.   EUROPEAN JOURNAL OF CANCER

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY